Biofrontera Inc.
1.04
-0.09 (-7.96%)
At close: Jan 14, 2025, 3:59 PM
1.01
-3.35%
Pre-market Jan 15, 2025, 07:49 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 34.07M 28.67M 24.10M 18.85M 26.18M
Cost of Revenue 17.44M 15.19M 12.74M 9.07M 12.41M
Gross Profit 16.63M 13.49M 11.36M 9.78M 13.77M
Operating Income -22.68M -22.38M -25.85M -8.33M -14.92M
Interest Income 132.00K 175.00K 16.00K 28.00K 25.00K
Pretax Income -20.12M -608.00K -37.66M -10.92M -10.95M
Net Income -20.13M -640.00K -37.71M -10.99M -10.98M
Selling & General & Admin 39.13M 35.87M 37.21M 18.12M 28.70M
Research & Development 77.00K n/a n/a n/a n/a
Other Expenses 100.00K 33.00K 689.00K 1.25M 5.48M
Operating Expenses 39.30M 35.87M 37.21M 18.12M 28.70M
Interest Expense 600.00K 195.00K 344.00K 2.90M 2.16M
Selling & Marketing Expenses 1.43M 100.00K 500.00K n/a n/a
Cost & Expenses 56.75M 51.05M 49.95M 27.18M 41.10M
Income Tax 14.00K 32.00K 56.00K 64.00K 33.00K
Shares Outstanding (Basic) 1.55M 1.06M 855.24K 580.00K 607.00K
Shares Outstanding (Diluted) 1.55M 1.06M 855.24K 580.00K 607.00K
EPS (Basic) -13.02 -0.61 -44.1 -18.94 -18.09
EPS (Diluted) -13.02 -0.61 -44.1 -18.94 -18.09
EBITDA -18.45M 934.00K -36.76M -7.49M -8.15M
Depreciation & Amortization 1.06M 1.17M 540.00K 562.00K 667.00K